G2019S LRRK2 Kinase Inhibition in Heterozygous Mice Avoids Lung Phenotype Observed with Inhibition of WT LRRK2

Authors

Institutions

Publication Details

Journal
ACS Chemical Neuroscience
Published
2026-07-26
DOI
https://doi.org/10.1021/acschemneuro.6c00147
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

G2019S LRRK2 Kinase Inhibition in Heterozygous Mice Avoids Lung Phenotype Observed with Inhibition of WT LRRK2

Matteo Santoro, Albert W. Garofalo, Thomas J. Montine, R. Jeremy Nichols et al.
ACS Chemical Neuroscience
Lung Cancer Treatments and Mutations
article

G2019S LRRK2 Kinase Inhibition in Heterozygous Mice Avoids Lung Phenotype Observed with Inhibition of WT LRRK2

Matteo Santoro, Albert W. Garofalo, Thomas J. Montine, R. Jeremy Nichols, Marcus D. Schonemann, Jing Zhao
article en

Abstract

No abstract available for this paper.
ACS Chemical Neuroscience
Stanford University (US)
Zero hunger
Openalex Percentile: Top 9%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

G2019S LRRK2 Kinase Inhibition in Heterozygous Mice Avoids Lung Phenotype Observed with Inhibition of WT LRRK2 — Matteo Santoro, Albert W. Garofalo, et al. · ACS Chemical Neuroscience (2026) | TGRS Research Map | TGRS